479 related articles for article (PubMed ID: 24836546)
21. Narrowband UVB as an effective substitute for psoralen plus UVA: lessons from a psoralen shortage.
Drucker AM; Baibergenova A; Rosen CF; Shear NH
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):267-8. PubMed ID: 22971194
[TBL] [Abstract][Full Text] [Related]
22. Broad band UVA: a possible reliable alternative to PUVA in the treatment of early-stage mycosis fungoides.
El Mofty M; Ramadan S; Fawzy MM; Hegazy RA; Sayed S
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):274-7. PubMed ID: 22971197
[TBL] [Abstract][Full Text] [Related]
23. Folliculotropic mycosis fungoides in a pediatric patient with response to psoralen-ultraviolet A phototherapy.
Boix-Vilanova J; Corral-Magaña O; Martin-Santiago A; Escalas J
Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):54-56. PubMed ID: 30007081
[TBL] [Abstract][Full Text] [Related]
24. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
[TBL] [Abstract][Full Text] [Related]
25. Phototherapy of Mycosis Fungoides.
Hodak E; Pavlovsky L
Dermatol Clin; 2015 Oct; 33(4):697-702. PubMed ID: 26433842
[TBL] [Abstract][Full Text] [Related]
26. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
[TBL] [Abstract][Full Text] [Related]
27. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
28. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
[TBL] [Abstract][Full Text] [Related]
29. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
31. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
Huang J; Cowper S; Moss J; Girardi M
J Drugs Dermatol; 2013 Apr; 12(4):487-9. PubMed ID: 23652902
[TBL] [Abstract][Full Text] [Related]
32. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium.
Olsen EA; Hodak E; Anderson T; Carter JB; Henderson M; Cooper K; Lim HW
J Am Acad Dermatol; 2016 Jan; 74(1):27-58. PubMed ID: 26547257
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of bath-psoralen and ultraviolet A therapy for mycosis fungoides - retrospective analysis of 62 cases.
Shintani Y; Nishida E; Furuhashi T; Muramatsu S; Kubo R; Nakamura M; Watanabe S; Masuda H; Ikumi K; Matsumoto K; Yamazaki S; Morita A
J Dermatol; 2022 Feb; 49(2):239-245. PubMed ID: 34309912
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of systemic psoralen and ultraviolet A and narrowband ultraviolet B in treatment of chronic urticaria.
Khafagy NH; Salem SA; Ghaly EG
Photodermatol Photoimmunol Photomed; 2013 Feb; 29(1):12-7. PubMed ID: 23281692
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of low-dose bexarotene and PUVA in the treatment of patients with mycosis fungoides.
Papadavid E; Antoniou C; Nikolaou V; Siakantaris M; Vassilakopoulos TP; Stratigos A; Stavrianeas N; Katsambas A
Am J Clin Dermatol; 2008; 9(3):169-73. PubMed ID: 18429646
[TBL] [Abstract][Full Text] [Related]
36. PUVA therapy and narrowband UVB therapy in Tunisian patients with mycosis fungoides.
Khaled A; Fazaa B; Goucha S; Zeglaoui F; Kamoun MR
Therapie; 2009; 64(6):389-94. PubMed ID: 20025842
[TBL] [Abstract][Full Text] [Related]
37. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis.
Hofer A; Fink-Puches R; Kerl H; Quehenberger F; Wolf P
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):1-5. PubMed ID: 16436174
[TBL] [Abstract][Full Text] [Related]
38. UVB in the management of early stage mycosis fungoides.
Pavlotsky F; Barzilai A; Kasem R; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2006 May; 20(5):565-72. PubMed ID: 16684285
[TBL] [Abstract][Full Text] [Related]
39. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study.
Berneburg M; Herzinger T; Rampf J; Hoetzenecker W; Guenova E; Meisner C; Maetzke J; Schaefer T; Eberlein B; Scharffetter-Kochanek K; Rocken M
Br J Dermatol; 2013 Sep; 169(3):704-8. PubMed ID: 23772997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]